Skip to content
DraconiticResearch
Search Sources API
220,595 studies31 sourcesUpdated 48 min ago
Peer-reviewedCC BY-NC-ND 4.0Annals of Transplantation

Retrospective Study of Implementation and Outcomes of a Non-Cryopreserved Autologous Hematopoietic Stem Cell Transplantation Program for Patients With Hematologic Malignancy in a Resource-Limited Center in Chile

  • Blaz Lesina1,2
  • Susana Calderón1
  • Vivianne Torres1,2
  • José Salinas1,2
  • Esteban Teneb3,4
  • Diego Reyes5
  • collaborators
5 affiliations
  1. 1Hematology Section, Department of Medicine, Hospital Base Valdivia, Valdivia, Chile
  2. 2Department of Hematology, Universidad Austral de Chile, Valdivia, Chile
  3. 3Infectious Diseases Unit, Hospital Base Valdivia, Valdivia, Chile
  4. 4Department of Infectious Diseases, Universidad Austral de Chile, Valdivia, Chile
  5. 5Clinical Pharmacist, Hospital Base Valdivia, Valdivia, Chile
Read full textPDFDOICite

Abstract

Background: Autologous hematopoietic progenitor cell transplantation (ASCT) is the standard treatment for many hematologic malignancies, and is usually performed with cryopreservation. However, many centers in resource-limited settings perform ASCT without cryopreservation. This retrospective study evaluated the feasibility and outcomes of implementing a non-cryopreserved ASCT program for hematologic malignancy in a public health system hospital in Chile, located far from the capital city and without local cryopreservation facilities.

Material/Methods: A retrospective study of consecutive peripheral blood ASCT procedures was performed at Hospital Base Valdivia in patients older than 15 and younger than 62 years, between June 2018 and July 2024. Data were extracted from patients’ medical records. Overall survival was estimated using the Kaplan-Meier method and hazard ratios, and 95% confidence intervals were calculated using univariable Cox proportional hazards models.

Results: A total of 140 patients underwent ASCT: 81 with multiple myeloma, 31 with Hodgkin lymphoma, and 28 with non-Hodgkin lymphoma. Mobilization failure occurred in 4 patients. There was no transplant-related mortality or graft failure. Median time to neutrophil engraftment was 10.9 days, and median time to platelet engraftment was 12.3 days. Febrile neutropenia occurred in 45% of patients. Overall survival at 6 years was 83% for the entire cohort, and 96%, 88%, and 76% for non-Hodgkin lymphoma, Hodgkin lymphoma, and multiple myeloma, respectively (P = 0.41).

Conclusions: In this retrospective single-center public-hospital experience, non-cryopreserved ASCT was feasible without local backup cryopreservation facilities, and was associated with acceptable engraftment, early transplant-related mortality, and encouraging survival outcomes.

Related

  1. The perceptions of hematopoietic stem cell transplantation decision-making in patients with hematologic malignancies: a qualitative systematic review.
    QingYing Wu, DanQi Chen, Fei Yuan +4
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Efficacy of Unrelated Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia: A Single-Center Retrospective Study.
    Jinrong Zhao, Liangliang Wu, Ming Zhou +11
    International journal of medical sciencesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Haploidentical hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for severe aplastic anemia patients aged 40-65: a multicenter retrospective study.
    Xiaohui Xiao, Guiping Chen, Cong Xu +11
    Annals of hematologyPeer-reviewedCC BYFull textGeneral medicineEurope PMCDOAJ
  4. Rectal colonization with multidrug-resistant organisms in adult acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective, longitudinal, single-center study
    Edoardo Tamellini, Chiara Bonetto, Annarita Mazzariol +8
    Frontiers in cellular and infection microbiologyPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  5. Addition of thiotepa to total body irradiation-based conditioning in allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute leukemia and lymphoma: a propensity score-matched retrospective study.
    Minglu Li, Shuqin Zhang, Xiaoyong Man +4
    Annals of hematologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCDOAJ

Cite

BibTeXRIS
BibTeX
@article{lesina2026retrospective,
  title = {{Retrospective Study of Implementation and Outcomes of a Non-Cryopreserved Autologous Hematopoietic Stem Cell Transplantation Program for Patients With Hematologic Malignancy in a Resource-Limited Center in Chile}},
  author = {Blaz Lesina and Susana Calderón and Vivianne Torres and José Salinas and Esteban Teneb and Diego Reyes and collaborators},
  journal = {Annals of Transplantation},
  year = {2026},
  month = nov,
  doi = {10.12659/aot.954230},
  url = {https://doi.org/10.12659/aot.954230},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Retrospective Study of Implementation and Outcomes of a Non-Cryopreserved Autologous Hematopoietic Stem Cell Transplantation Program for Patients With Hematologic Malignancy in a Resource-Limited Center in Chile
AU  - Blaz Lesina
AU  - Susana Calderón
AU  - Vivianne Torres
AU  - José Salinas
AU  - Esteban Teneb
AU  - Diego Reyes
AU  - collaborators
PY  - 2026
DA  - 2026/11/03
JO  - Annals of Transplantation
DO  - 10.12659/aot.954230
UR  - https://doi.org/10.12659/aot.954230
AB  - Background: Autologous hematopoietic progenitor cell transplantation (ASCT) is the standard treatment for many hematologic malignancies, and is usually performed with cryopreservation. However, many centers in resource-limited settings perform ASCT without cryopreservation. This retrospective study evaluated the feasibility and outcomes of implementing a non-cryopreserved ASCT program for hematologic malignancy in a public health system hospital in Chile, located far from the capital city and without local cryopreservation facilities.  Material/Methods: A retrospective study of consecutive peripheral blood ASCT procedures was performed at Hospital Base Valdivia in patients older than 15 and younger than 62 years, between June 2018 and July 2024. Data were extracted from patients’ medical records. Overall survival was estimated using the Kaplan-Meier method and hazard ratios, and 95% confidence intervals were calculated using univariable Cox proportional hazards models.  Results: A total of 140 patients underwent ASCT: 81 with multiple myeloma, 31 with Hodgkin lymphoma, and 28 with non-Hodgkin lymphoma. Mobilization failure occurred in 4 patients. There was no transplant-related mortality or graft failure. Median time to neutrophil engraftment was 10.9 days, and median time to platelet engraftment was 12.3 days. Febrile neutropenia occurred in 45% of patients. Overall survival at 6 years was 83% for the entire cohort, and 96%, 88%, and 76% for non-Hodgkin lymphoma, Hodgkin lymphoma, and multiple myeloma, respectively (P = 0.41).  Conclusions: In this retrospective single-center public-hospital experience, non-cryopreserved ASCT was feasible without local backup cryopreservation facilities, and was associated with acceptable engraftment, early transplant-related mortality, and encouraging survival outcomes.
SN  - 1425-9524
SN  - 2329-0358
ER  -